Global Tasigna Market, By Type (50mg, 200mg, Others), Application (Chronic Myeloid Leukemia (CML), Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Demographic (Adults, Pediatric), Side Effects (Headache, Nausea, Vomiting, Constipation, Cough, Diarrhea, Rash, Night Sweats, Muscle Pain, Tiredness, Temporary Hair Loss, Sore Throat, Runny or Stuffy Nose, Sneezing, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.